XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in Capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury Stock
Balance, beginning of the period (in shares) at Mar. 31, 2020   143,938,753       (78,081,314)
Balance, beginning of the period at Mar. 31, 2020 $ 1,087,512 $ 14,394 $ 1,496,565 $ 1,545,094 $ 5,745 $ (1,974,286)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   566,704       (174,622)
Employee stock awards, benefit plans and other issuances (705) $ 56 8,621     $ (9,382)
Non-cash stock-based compensation (in shares)   17,548        
Non-cash stock-based compensation 44,917 $ 2 44,915      
Restricted stock units vested (in shares)   1,169,530        
Restricted stock units vested   $ 117 (117)      
Acquisition of treasury stock (in shares)           (1,321,666)
Acquisition of treasury stock (42,312)         $ (42,312)
Liability-classified restricted stock units vested (in shares)   780,400        
Liability-classified restricted stock units vested 24,441 $ 78 24,363      
Other comprehensive income (loss):            
Foreign currency translation 2,069       2,069  
Net loss (57,421)     (57,421)    
Balance, end of the period (in shares) at Dec. 31, 2020   146,472,935       (79,577,602)
Balance, end of the period at Dec. 31, 2020 1,058,501 $ 14,647 1,574,347 1,487,673 7,814 $ (2,025,980)
Balance, beginning of the period (in shares) at Sep. 30, 2020   145,705,138       (79,516,592)
Balance, beginning of the period at Sep. 30, 2020 1,050,862 $ 14,570 1,552,303 1,499,398 6,944 $ (2,022,353)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   371,888       (61,010)
Employee stock awards, benefit plans and other issuances 1,489 $ 37 5,079     $ (3,627)
Non-cash stock-based compensation (in shares)   3,997        
Non-cash stock-based compensation 17,005 $ 1 17,004      
Restricted stock units vested (in shares)   391,912        
Restricted stock units vested   $ 39 (39)      
Other comprehensive income (loss):            
Foreign currency translation 870       870  
Net loss (11,725)     (11,725)    
Balance, end of the period (in shares) at Dec. 31, 2020   146,472,935       (79,577,602)
Balance, end of the period at Dec. 31, 2020 1,058,501 $ 14,647 1,574,347 1,487,673 7,814 $ (2,025,980)
Balance, beginning of the period (in shares) at Mar. 31, 2021   147,814,965       (79,585,710)
Balance, beginning of the period at Mar. 31, 2021 1,080,683 $ 14,781 1,630,072 1,454,826 7,522 $ (2,026,518)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   237,951       (280,521)
Employee stock awards, benefit plans and other issuances (8,033) $ 24 6,159     $ (14,216)
Non-cash stock-based compensation (in shares)   44,729        
Non-cash stock-based compensation 43,238 $ 5 43,233      
Restricted stock units vested (in shares)   895,230        
Restricted stock units vested   $ 89 (89)      
Acquisition of treasury stock (in shares)           (1,111,860)
Acquisition of treasury stock (49,224)         $ (49,224)
Acquisition-related restricted stock award (in shares)   40,600        
Acquisition-related restricted stock award   $ 4 (4)      
Liability-classified restricted stock units vested (in shares)   218,414        
Liability-classified restricted stock units vested 9,823 $ 22 9,801      
Other comprehensive income (loss):            
Foreign currency translation (1,632)       (1,632)  
Net loss (4,441)     (4,441)    
Balance, end of the period (in shares) at Dec. 31, 2021   149,251,889       (80,978,091)
Balance, end of the period at Dec. 31, 2021 1,070,414 $ 14,925 1,689,172 1,450,385 5,890 $ (2,089,958)
Balance, beginning of the period (in shares) at Sep. 30, 2021   148,870,184       (80,831,781)
Balance, beginning of the period at Sep. 30, 2021 1,072,947 $ 14,887 1,669,461 1,465,760 5,976 $ (2,083,137)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   71,721       (31,264)
Employee stock awards, benefit plans and other issuances 231 $ 7 1,898     $ (1,674)
Non-cash stock-based compensation (in shares)   6,815        
Non-cash stock-based compensation 17,844 $ 1 17,843      
Restricted stock units vested (in shares)   303,169        
Restricted stock units vested 0 $ 30 (30)      
Acquisition of treasury stock (in shares)           (115,046)
Acquisition of treasury stock (5,147)         $ (5,147)
Other comprehensive income (loss):            
Foreign currency translation (86)       (86)  
Net loss (15,375)     (15,375)    
Balance, end of the period (in shares) at Dec. 31, 2021   149,251,889       (80,978,091)
Balance, end of the period at Dec. 31, 2021 $ 1,070,414 $ 14,925 $ 1,689,172 $ 1,450,385 $ 5,890 $ (2,089,958)